Abstract | INTRODUCTION: METHODS: This crossover study, conducted in eight healthy young men, was double-blind, randomized and placebo-controlled. It was performed on 2 trial days, separated by a 4-week washout period. The volunteers received an infusion of alanine- glutamine at a rate of 0.025 g/(kg body weight x hour) or saline for 10 hours. After 2 hours, an intravenous bolus of Escherichia coli endotoxin (0.3 ng/kg) was administered. Blood samples were collected hourly for the following 8 hours. HSP70 protein content in isolated blood mononuclear cells (BMNCs) was measured by Western blotting. RESULTS: CONCLUSIONS: TRIAL REGISTRATION: ClinicalTrials.gov ID: NCT 00780520.
|
Authors | Anne Sofie Andreasen, Theis Pedersen-Skovsgaard, Ole Hartvig Mortensen, Gerrit van Hall, Pope Lloyd Moseley, Bente Klarlund Pedersen |
Journal | Critical care (London, England)
(Crit Care)
Vol. 13
Issue 1
Pg. R7
( 2009)
ISSN: 1466-609X [Electronic] England |
PMID | 19173710
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Endotoxins
- HSP70 Heat-Shock Proteins
- Inflammation Mediators
- Glutamine
|
Topics |
- Adult
- Cross-Over Studies
- Double-Blind Method
- Endotoxemia
(blood, chemically induced)
- Endotoxins
(toxicity)
- Glutamine
(administration & dosage, blood)
- HSP70 Heat-Shock Proteins
(biosynthesis, metabolism)
- Humans
- Inflammation
(blood, chemically induced)
- Inflammation Mediators
(blood)
- Infusions, Intravenous
- Male
- Young Adult
|